CY2014041I2 - 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια - Google Patents

2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια

Info

Publication number: CY2014041I2
Authority: CY; Cyprus
Prior art keywords: nitroimidazo; oxazole; dihydro
Prior art date: 2002-10-11

Application number

CY2014041C

Other languages

English (en)

Other versions

CY2014041I1 (el

Original Assignee

Otsuka Pharmaceutical Co., Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-11

Filing date

2014-09-24

Publication date

2016-07-27

2014-09-24 Application filed by Otsuka Pharmaceutical Co., Ltd filed Critical Otsuka Pharmaceutical Co., Ltd

2016-07-27 Publication of CY2014041I1 publication Critical patent/CY2014041I1/el

2016-07-27 Publication of CY2014041I2 publication Critical patent/CY2014041I2/el

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

CY2014041C 2002-10-11 2014-09-24 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια CY2014041I2 (el)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2002298259		2002-10-11
PCT/JP2003/013070 WO2004033463A1 (ja)	2002-10-11	2003-10-10	２，３−ジヒドロ−６−ニトロイミダゾ[２，１−ｂ]オキサゾール化合物

Publications (2)

Publication Number	Publication Date
CY2014041I1 CY2014041I1 (el)	2016-07-27
CY2014041I2 true CY2014041I2 (el)	2016-07-27

Family

ID=32089299

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CY20131100076T CY1113578T1 (el)	2002-10-11	2013-01-25	2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
CY2014041C CY2014041I2 (el)	2002-10-11	2014-09-24	2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CY20131100076T CY1113578T1 (el)	2002-10-11	2013-01-25	2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια

Country Status (27)

Country	Link
US (1)	US7262212B2 (el)
EP (2)	EP2570418A3 (el)
JP (1)	JP4186065B2 (el)
KR (1)	KR100723847B1 (el)
CN (4)	CN102532162B (el)
AR (4)	AR041198A1 (el)
AU (1)	AU2003272979B2 (el)
BE (1)	BE2014C053I2 (el)
BR (1)	BRPI0314344B8 (el)
CA (1)	CA2497569C (el)
CY (2)	CY1113578T1 (el)
DK (1)	DK1555267T3 (el)
ES (1)	ES2400179T3 (el)
FR (1)	FR14C0066I2 (el)
HK (2)	HK1085463A1 (el)
HU (1)	HUS1400046I1 (el)
LU (1)	LU92517I2 (el)
MX (1)	MXPA05003674A (el)
MY (1)	MY139244A (el)
PL (3)	PL217919B1 (el)
PT (1)	PT1555267E (el)
RU (1)	RU2326121C3 (el)
SI (1)	SI1555267T1 (el)
TW (1)	TWI347946B (el)
UA (1)	UA83200C2 (el)
WO (1)	WO2004033463A1 (el)
ZA (1)	ZA200501033B (el)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60144284D1 (de)	2000-11-01	2011-05-05	Millennium Pharm Inc	Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung
ES2526892T3 (es) *	2002-10-15	2015-01-16	Otsuka Pharmaceutical Co., Ltd.	Método para preparar un compuesto 2-halo-4-nitroimidazol
JP4761756B2 (ja) *	2003-10-31	2011-08-31	大塚製薬株式会社	２，３−ジヒドロイミダゾ［２，１−ｂ］オキサゾ−ル化合物
US8163753B2 (en) *	2003-10-31	2012-04-24	Otsuka Pharmaceutical Co., Ltd.	2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis
TWI300409B (en)	2004-02-18	2008-09-01	Otsuka Pharma Co Ltd	Method for producing 4-nitroimidazole compound
PT1731518E (pt)	2004-03-31	2014-09-18	Nippon Soda Co	Composto amina cíclico e agente de controlo de pragas
JP4789966B2 (ja) *	2004-04-09	2011-10-12	大塚製薬株式会社	医薬組成物
JP4787529B2 (ja) *	2004-04-09	2011-10-05	大塚製薬株式会社	医薬組成物
EP1896453B1 (en) *	2005-06-20	2009-12-02	Schering Corporation	Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
RU2413504C3 (ru) *	2005-07-28	2021-10-05	Оцука Фармасьютикал Ко., Лтд.	ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ПРОИЗВОДНЫЕ 2,3-ДИГИДРО-6-НИТРОИМИДАЗО[2,1-b]ОКСАЗОЛА
JP5105818B2 (ja) *	2005-10-05	2012-12-26	大塚製薬株式会社	医薬組成物
TW201233389A (en) *	2005-10-05	2012-08-16	Otsuka Pharma Co Ltd	Antituberculous therapeutic drugs and kit containing the same
PT1947098E (pt)	2005-10-06	2012-01-12	Nippon Soda Co	Compostos de amina cíclicos e agente para controlo de pragas
TW200800268A (en) *	2005-11-04	2008-01-01	Otsuka Pharma Co Ltd	Medicinal composition showing improved drug absorbability
EP1968961A2 (en) *	2005-12-21	2008-09-17	Decode Genetics EHF	Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
US20090018169A1 (en) *	2006-02-13	2009-01-15	Laboratoires Serono Sa	Sulfonamide Derivatives for the Treatment of Bacterial Infections
JP2007297305A (ja) *	2006-04-28	2007-11-15	Daiso Co Ltd	Ｎ−（２，３−エポキシ−２−メチルプロピル）フタルイミドの製造法
JP5486928B2 (ja) *	2007-02-26	2014-05-07	ヴァイティーファーマシューティカルズ，インコーポレイテッド	１１β−ヒドロキシステロイドデヒドロゲナーゼ１のサイクリックウレアおよびカルバメートインヒビター
AR070301A1 (es)	2007-05-08	2010-03-31	Otsuka Pharma Co Ltd	Compuesto epoxi y metodo para producir el mismo
WO2009017664A1 (en) *	2007-07-26	2009-02-05	Vitae Pharmaceuticals, Inc.	CYCLIC INHIBITORS OF 11β-HYDROXYSTERIOD DEHYDROGENASE 1
AR067927A1 (es) *	2007-08-15	2009-10-28	Glaxo Group Ltd	Quinolinas sustituidas, composiciones y combinaciones que las comprenden y el uso de las mismas en la preparacion de un medicamento para tratamiento de enfermedades inflamatorias y/o alergicas del tracto respiratorio.
US20100222349A1 (en) *	2007-10-16	2010-09-02	Glaxo Group Limited	Quinoline derivatives used to treat inflammatory and allergic diseases
AR069207A1 (es) *	2007-11-07	2010-01-06	Vitae Pharmaceuticals Inc	Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
JP5490014B2 (ja)	2007-12-11	2014-05-14	ヴァイティーファーマシューティカルズ，インコーポレイテッド	１１β−ヒドロキシステロイドデヒドロゲナーゼ１型の環状尿素阻害剤
TW200934490A (en) *	2008-01-07	2009-08-16	Vitae Pharmaceuticals Inc	Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
JP5490020B2 (ja)	2008-01-24	2014-05-14	ヴァイティーファーマシューティカルズ，インコーポレイテッド	１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状カルバゼート及びセミカルバジドインヒビター
WO2009102428A2 (en) *	2008-02-11	2009-08-20	Vitae Pharmaceuticals, Inc.	1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
JP5730021B2 (ja) *	2008-02-15	2015-06-03	ヴァイティーファーマシューティカルズ，インコーポレイテッド	１１β−ヒドロキシステロイドデヒドロゲナーゼ１の阻害剤としてのシクロアルキルラクタム誘導体
JP5538356B2 (ja) *	2008-03-18	2014-07-02	ヴァイティーファーマシューティカルズ，インコーポレイテッド	１１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤
JP5613656B2 (ja) *	2008-03-26	2014-10-29	グローバル、アライアンス、フォア、ティービー、ドラッグ、ディベロップメント	置換されたフェニルオキサゾリジノンと共有結合した二環式ニトロイミダゾール
EP2291371B1 (en)	2008-05-01	2015-06-10	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723034A1 (en)	2008-05-01	2009-11-05	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
RU2531272C2 (ru) *	2008-05-01	2014-10-20	Вайтаи Фармасьютиклз, Инк.	Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1
JP5451752B2 (ja) *	2008-05-01	2014-03-26	ヴァイティーファーマシューティカルズ，インコーポレイテッド	１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
TW201016691A (en)	2008-07-25	2010-05-01	Boehringer Ingelheim Int	Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CN102119160B (zh)	2008-07-25	2014-11-05	贝林格尔·英格海姆国际有限公司	11β-羟基类固醇脱氢酶1的环状抑制剂
US20120040974A1 (en) *	2008-08-18	2012-02-16	Yale University	Mif modulators
US9643922B2 (en)	2008-08-18	2017-05-09	Yale University	MIF modulators
US9540322B2 (en)	2008-08-18	2017-01-10	Yale University	MIF modulators
WO2010143007A1 (en) *	2009-06-10	2010-12-16	Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik	Method for the production of 2-halogeno-4-nitroimidazole
ES2476967T3 (es)	2008-08-21	2014-07-15	Dynamit Nobel Gmbh Explosivstoff- Und Systemtechnik	Métodos para la producción de 2-halo-4-nitroimidazol e intermedios del mismo
CA2744946A1 (en)	2009-02-04	2010-08-12	Boehringer Ingelheim International Gmbh	Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW201039034A (en) *	2009-04-27	2010-11-01	Chunghwa Picture Tubes Ltd	Pixel structure and the method of forming the same
GEP20156309B (en) *	2009-04-30	2015-07-10	Vitae Pharmaceuticals Inc	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
UA109255C2 (ru)	2009-04-30	2015-08-10	Берінгер Інгельхайм Інтернешнл Гмбх	Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
EP2440537A1 (en)	2009-06-11	2012-04-18	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
EP2448928B1 (en)	2009-07-01	2014-08-13	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US9198913B2 (en)	2009-07-31	2015-12-01	Global Alliance For Tb Drug Development	Nitroimidazooxazines and their uses in anti-tubercular therapy
CA2769263C (en) *	2009-07-31	2017-03-07	Global Alliance For Tb Drug Development	Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
NZ598121A (en) *	2009-07-31	2013-04-26	Global Alliance For Tb Drug Dev	Nitroimidazooxazines and their uses in anti-tubercular therapy
EP2495563A4 (en)	2009-10-26	2013-04-10	Fujifilm Ri Pharma Co Ltd	DIAGNOSTIC AGENT FOR INFECTIOUS DISEASES
TW201200523A (en)	2010-01-29	2012-01-01	Otsuka Pharma Co Ltd	Synthetic intermediate of oxazole compound and method for producing the same
GB201012209D0 (en) *	2010-05-31	2010-09-08	Ge Healthcare Ltd	In vivo imaging agent
EP2582698B1 (en)	2010-06-16	2016-09-14	Vitae Pharmaceuticals, Inc.	Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
WO2011161128A1 (en)	2010-06-25	2011-12-29	Boehringer Ingelheim International Gmbh	Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
JP2013540801A (ja)	2010-11-02	2013-11-07	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	代謝異常の治療のための組合せ医薬
CN103596960B (zh)	2011-04-15	2016-11-16	大塚制药株式会社	6,7-二氢咪唑并[2,1-b][1,3]噁嗪杀菌剂
JP2015006994A (ja) *	2011-10-28	2015-01-15	大正製薬株式会社	ジヒドロイミダゾオキサゾール誘導体
WO2014014845A1 (en)	2012-07-18	2014-01-23	Vertex Pharmaceuticals Incorporated	Combination therapy comprising\|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-\|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium\|diseases
FR3000064A1 (fr)	2012-12-21	2014-06-27	Univ Lille Ii Droit & Sante	Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
US9845330B2 (en) *	2013-10-04	2017-12-19	Council Of Scientific & Industrial Research	6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for the preparation thereof
CN103524492A (zh) *	2013-10-23	2014-01-22	中国药科大学	侧链含硝基咪唑基团取代的喹诺酮类化合物、其制备及用途
TWI687409B (zh)	2014-08-28	2020-03-11	日商大塚製藥股份有限公司	稠合雜環化合物
JP6467042B2 (ja) *	2014-10-21	2019-02-06	カウンシルオブサイエンティフィックアンドインダストリアルリサーチ	抗マイコバクテリア剤としての置換１，２，３−トリアゾール−１−イル−メチル−２，３−ジヒドロ−２−メチル−６−ニトロイミダゾ［２，１−ｂ］オキサゾールとその調製方法
CN105732659B (zh) *	2014-12-12	2019-07-16	上海阳帆医药科技有限公司	硝基咪唑类化合物及其制备方法和在制药中的用途
MX2017009810A (es)	2015-01-29	2018-11-09	Medshine Discovery Inc	Derivado de nitroimidazol contra tuberculosis pulmonar.
KR102597449B1 (ko)	2015-03-27	2023-11-03	오츠카 세이야쿠 가부시키가이샤	1-(4-히드록시페닐)-4-(4-트리플루오로메톡시페녹시)피페리딘 또는 그 염의 제조방법
CN106317072B (zh) *	2015-06-17	2020-03-17	盟科医药技术(上海)有限公司	用于分枝杆菌感染治疗的杂环化合物及其应用
WO2017146246A1 (ja)	2016-02-26	2017-08-31	大塚製薬株式会社	ピペリジン誘導体
CN105859628B (zh) *	2016-04-19	2018-08-07	清远职业技术学院	一种抗菌化合物对n咪唑苯甲醛缩邻甲苯胺希夫碱及其制备方法和应用
US20190276475A1 (en) *	2016-07-22	2019-09-12	Medshine Discovery Inc.	Crystal and salt of nitroimidazole, and manufacturing method thereof
PL3668879T3 (pl) *	2017-08-16	2022-02-21	Glaxosmithkline Intellectual Property Development Limited	Nowe związki
SG11202011908YA (en)	2018-06-11	2020-12-30	Otsuka Pharma Co Ltd	Delamanid-containing composition
CN109705022A (zh) *	2018-12-28	2019-05-03	上海彩迩文生化科技有限公司	一种芳香胺中间体的制备方法
CN112300192B (zh) *	2019-08-02	2023-08-11	南京长澳医药科技有限公司	硝基咪唑类化合物及其制备方法和用途
CN110483549B (zh) *	2019-08-30	2021-03-05	沈阳药科大学	一种硝基咪唑吡喃类抗结核药物的制备方法
CN110615800A (zh) *	2019-10-16	2019-12-27	李丽丽	硝基咪唑类化合物及其制备方法和用途
CN112156088B (zh) *	2020-10-30	2021-08-31	健民药业集团股份有限公司	一种化合物在制备结核分枝杆菌抑制剂中的用途
CN113603706A (zh) *	2021-08-04	2021-11-05	深圳市泰力生物医药有限公司	德拉马尼的晶型、含有该晶型的活性药物和药物组合物
WO2024024938A1 (ja)	2022-07-29	2024-02-01	大塚製薬株式会社	デラマニド含有固体分散体
CN115368252B (zh) *	2022-09-19	2024-01-12	西北农林科技大学	一种4-胺基酚类衍生物及应用
CN116640106B (zh) *	2023-05-11	2024-03-08	郑州大学	一种苯基哌嗪类化合物及其制备方法、应用
CN119059990B (zh) *	2024-11-01	2025-02-07	安徽昊帆生物有限公司	1-氨基甲酸叔丁酯哌嗪的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5668127A (en)	1995-06-26	1997-09-16	Pathogenesis Corporation	Nitroimidazole antibacterial compounds and methods of use thereof

2003
- 2003-10-09 AR ARP030103673A patent/AR041198A1/es active IP Right Grant
- 2003-10-09 TW TW092128165A patent/TWI347946B/zh not_active IP Right Cessation
- 2003-10-10 WO PCT/JP2003/013070 patent/WO2004033463A1/ja active Application Filing
- 2003-10-10 AU AU2003272979A patent/AU2003272979B2/en not_active Expired
- 2003-10-10 PT PT37540853T patent/PT1555267E/pt unknown
- 2003-10-10 PL PL376157A patent/PL217919B1/pl unknown
- 2003-10-10 ES ES03754085T patent/ES2400179T3/es not_active Expired - Lifetime
- 2003-10-10 US US10/530,429 patent/US7262212B2/en not_active Expired - Lifetime
- 2003-10-10 UA UAA200504391A patent/UA83200C2/ru unknown
- 2003-10-10 CN CN201110416170.4A patent/CN102532162B/zh not_active Expired - Lifetime
- 2003-10-10 CN CNA2007100040371A patent/CN101255170A/zh active Pending
- 2003-10-10 BR BRPI0314344A patent/BRPI0314344B8/pt not_active IP Right Cessation
- 2003-10-10 MX MXPA05003674A patent/MXPA05003674A/es active IP Right Grant
- 2003-10-10 CN CNB2003801017508A patent/CN100366624C/zh not_active Expired - Lifetime
- 2003-10-10 EP EP12193820.3A patent/EP2570418A3/en not_active Withdrawn
- 2003-10-10 CA CA2497569A patent/CA2497569C/en not_active Expired - Lifetime
- 2003-10-10 KR KR1020057004567A patent/KR100723847B1/ko active Protection Beyond IP Right Term
- 2003-10-10 CN CNA2007100040367A patent/CN101172981A/zh active Pending
- 2003-10-10 EP EP03754085A patent/EP1555267B1/en not_active Expired - Lifetime
- 2003-10-10 PL PL409525A patent/PL409525A1/pl unknown
- 2003-10-10 MY MYPI20033866A patent/MY139244A/en unknown
- 2003-10-10 DK DK03754085.3T patent/DK1555267T3/da active
- 2003-10-10 RU RU2005114017A patent/RU2326121C3/ru active Protection Beyond IP Right Term
- 2003-10-10 SI SI200332254T patent/SI1555267T1/sl unknown
- 2003-10-10 PL PL404913A patent/PL404913A1/pl unknown
- 2003-10-14 JP JP2003353868A patent/JP4186065B2/ja not_active Expired - Lifetime
2005
- 2005-02-03 ZA ZA200501033A patent/ZA200501033B/en unknown
2006
- 2006-02-03 HK HK06101486A patent/HK1085463A1/xx not_active IP Right Cessation
2012
- 2012-04-23 AR ARP120101394A patent/AR086485A2/es unknown
- 2012-11-21 HK HK12111863.7A patent/HK1171018A1/xx not_active IP Right Cessation
2013
- 2013-01-25 CY CY20131100076T patent/CY1113578T1/el unknown
- 2013-02-08 AR ARP130100408A patent/AR089950A2/es unknown
- 2013-07-15 AR ARP130102514 patent/AR091771A2/es not_active Application Discontinuation
2014
- 2014-08-13 LU LU92517C patent/LU92517I2/xx unknown
- 2014-08-14 HU HUS1400046C patent/HUS1400046I1/hu unknown
- 2014-09-09 BE BE2014C053C patent/BE2014C053I2/fr unknown
- 2014-09-11 FR FR14C0066C patent/FR14C0066I2/fr active Active
- 2014-09-24 CY CY2014041C patent/CY2014041I2/el unknown

Also Published As

Publication number	Publication date
HUS1400046I1 (hu)	2017-04-28
KR100723847B1 (ko)	2007-05-31
TW200420568A (en)	2004-10-16
JP2004149527A (ja)	2004-05-27
PL409525A1 (pl)	2014-11-10
EP1555267B1 (en)	2013-01-16
JP4186065B2 (ja)	2008-11-26
EP2570418A2 (en)	2013-03-20
MXPA05003674A (es)	2005-06-08
TWI347946B (en)	2011-09-01
KR20050061473A (ko)	2005-06-22
PL217919B1 (pl)	2014-09-30
BR0314344A (pt)	2005-07-12
UA83200C2 (en)	2008-06-25
AR086485A2 (es)	2013-12-18
ZA200501033B (en)	2006-06-28
AR089950A2 (es)	2014-10-01
CN101255170A (zh)	2008-09-03
EP1555267A1 (en)	2005-07-20
BRPI0314344B8 (pt)	2021-05-25
RU2326121C2 (ru)	2008-06-10
CN100366624C (zh)	2008-02-06
CN102532162B (zh)	2015-05-27
CY2014041I1 (el)	2016-07-27
CN1705670A (zh)	2005-12-07
HK1085463A1 (en)	2006-08-25
RU2326121C3 (ru)	2021-09-17
CN102532162A (zh)	2012-07-04
FR14C0066I2 (fr)	2015-05-22
ES2400179T3 (es)	2013-04-08
CA2497569C (en)	2011-05-24
FR14C0066I1 (el)	2014-10-17
US7262212B2 (en)	2007-08-28
DK1555267T3 (da)	2013-02-11
BRPI0314344B1 (pt)	2019-11-26
CY1113578T1 (el)	2016-06-22
BE2014C053I2 (el)	2022-08-30
EP1555267A4 (en)	2010-08-18
CA2497569A1 (en)	2004-04-22
RU2005114017A (ru)	2006-01-20
EP2570418A3 (en)	2013-07-03
WO2004033463A1 (ja)	2004-04-22
MY139244A (en)	2009-09-30
AR091771A2 (es)	2015-02-25
AU2003272979A1 (en)	2004-05-04
US20060094767A1 (en)	2006-05-04
CN101172981A (zh)	2008-05-07
AU2003272979B2 (en)	2009-07-23
PL376157A1 (en)	2005-12-27
LU92517I2 (fr)	2014-10-13
SI1555267T1 (sl)	2013-05-31
HK1171018A1 (en)	2013-03-15
AR041198A1 (es)	2005-05-04
PT1555267E (pt)	2013-01-29
PL404913A1 (pl)	2013-09-30

Publication	Publication Date	Title
CY2014041I1 (el)	2016-07-27	2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
DK2308855T3 (da)	2013-01-28	2,4-Diaminopyrimidinderivater
DE602004006169D1 (de)	2007-06-06	Substituierte 8'-pyri(mi)dinyl-dihydrospiro-äcycloalkylaminü-pyrimidoä1,2aüpyrimidin-6-onderivate
ATE402152T1 (de)	2008-08-15	Hiv-inhibierende1,2,4-triazine
NO20053248D0 (no)	2005-07-01	Kerosenblanding.
DE60305332D1 (de)	2006-06-22	IMIDAZOi1,2-AöPYRIDINE
NO20052248D0 (no)	2005-05-09	Svivelstykkesystem.
DK1487778T3 (da)	2012-08-06	Substituerede 4 aminocyclohexanoler
FI20020881A0 (fi)	2002-05-08	Iskulaite
NO20051500D0 (no)	2005-03-21	Substituerte heterocyklylpyrimidiner.
ITMI20032170A1 (it)	2004-06-22	Tagliacimosse.
DE60315471D1 (de)	2007-09-20	2,5-disubstituierte 3-mercaptopentansaure
NO20051497D0 (no)	2005-03-21	Beta-laktamaseinhibitorprodrug.
NO20044405L (no)	2004-10-15	Neurotensinaktive 2,3-diaryl-pyrazolidin derivater
ITMI20030916A1 (it)	2003-11-23	Lancetta.
AT5889U3 (de)	2003-04-25	Brennholzspleisser
ES1052590Y (es)	2003-05-01	Quiosco-consigna.
SE0301847D0 (sv)	2003-06-25	Novel 3,3-Diphenylpropylamines
ES1052938Y (es)	2003-06-16	Cantonera.
ES1051703Y (es)	2003-01-16	Potera.
ES1052945Y (es)	2003-06-16	Contraventana.
ES1051110Y (es)	2002-10-16	Caja-palet.
ES1052654Y (es)	2003-05-01	Cubitera.
ES1051605Y (es)	2002-12-16	Cromo-puzzle.
ES1052029Y (es)	2003-03-01	Balin-proyectil.